...
首页> 外文期刊>Indian Journal of Medical Microbiology >Over-expression of gene encoding heat shock protein 70 from Mycobacterium tuberculosis and its evaluation as vaccine adjuvant
【24h】

Over-expression of gene encoding heat shock protein 70 from Mycobacterium tuberculosis and its evaluation as vaccine adjuvant

机译:结核分枝杆菌编码热休克蛋白70的基因的过表达及其作为疫苗佐剂的评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Heat shock proteins (Hsps) are evolutionary ancient and highly conserved molecular chaperons found in prokaryotes as well as eukaryotes. Hsp70 is a predominant member of Hsp family. Microbial Hsp70s (mHsp70s) have acquired special significance in immunity since they have been shown to be potent activators of the innate immune system and generate specific immune responses against tumours and infectious agents. Objectives: The present study was aimed to clone express and purify recombinant Hsp70 from the Mycobacterium tuberculosis and characterise it immunologically. The study also aimed at determining the potential of recombinant M. tuberculosis heat shock protein (rMTB-Hsp70) as adjuvant or antigen carrier. Materials and Methods: Cloning of M. tuberculosis heat shock protein (MTB-Hsp70) amplicon was carried out using the pGEMT-Easy vector although for expression, pProExHTb prokaryotic expression vector was used. Purification of recombinant Hsp70 was carried out by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography. For immunological characterization and determining the adjuvant effect of MTB-Hsp70, BALB/c mice were used. The data obtained was statistically analysed. Results: Hsp70 gene was cloned, sequenced and the sequence data were submitted to National Center for Biotechnology Information (NCBI). Recombinant MTB-Hsp70 was successfully over-expressed using the prokaryotic expression system and purified to homogeneity. The protein was found to be immunodominant. Significant adjuvant effect was produced by the rMTB-Hsp70 when inoculated with recombinant outer membrane protein 31; however, effect was less than the conventionally used the Freund's adjuvant. Conclusion: Protocol standardised can be followed for bulk production of rHsp70 in a cost-effective manner. Significant adjuvant effect was produced by rMTB-Hsp70; however, the effect was than Freund's adjuvant. Further, studies need to be carried out to explore its applicability as carrier of antigen.
机译:背景:热激蛋白(Hsps)是在原核生物和真核生物中发现的古老且高度保守的进化分子伴侣。 Hsp70是Hsp家族的主要成员。微生物Hsp70s(mHsp70s)在免疫方面具有特殊的意义,因为它们已被证明是先天免疫系统的有效激活剂,并产生针对肿瘤和传染原的特异性免疫反应。目的:本研究旨在从结核分枝杆菌中克隆表达和纯化重组Hsp70,并对其进行免疫学表征。该研究还旨在确定重组结核分枝杆菌热休克蛋白(rMTB-Hsp70)作为佐剂或抗原载体的潜力。材料和方法:尽管使用pProExHTb原核表达载体进行表达,但使用pGEMT-Easy载体克隆了结核分枝杆菌热休克蛋白(MTB-Hsp70)扩增子。重组Hsp70的纯化是通过镍-三氮三乙酸(Ni-NTA)亲和色谱法进行的。为了进行免疫学表征和确定MTB-Hsp70的佐剂作用,使用了BALB / c小鼠。对获得的数据进行统计分析。结果:克隆,测序Hsp70基因,并将序列数据提交给国家生物技术信息中心(NCBI)。使用原核表达系统成功重组MTB-Hsp70重组蛋白,并纯化至同质。发现该蛋白质具有免疫优势。 rMTB-Hsp70接种重组外膜蛋白31后,产生了显着的佐剂作用;然而,效果不如常规使用的弗氏佐剂。结论:可以按照标准化的协议以具有成本效益的方式批量生产rHsp70。 rMTB-Hsp70产生了显着的佐剂作用;但是,效果不如弗氏佐剂。此外,需要进行研究以探索其作为抗原载体的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号